Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Liraglutide
Victoza
Not routinely available
SMC (1192/16)
12/09/2016
Indication
As monotherapy for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control when diet and exercise alone do not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate due to intolerance or contraindications.
Therapeutic Area
Endocrine system
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
6mg/ml solution for injection in pre-filled pen
Comments
None
Link to Advice
Advice Published
12/09/2016
SMC Submission Type
Non submission
SMC Status
Not recommended